We have previously observed both elevated Rac1 level and elevated Rac1 activity in pancreatic cancer cells compared to normal pancreatic ductal cells [34], thus making hyper-activated Rac1 a promising therapeutic target for pancreatic cancers. The gene discussed is RAC1; the disease is pancreatic neoplasm.